A comprehensive view of Investigational New Drug Application (INDA). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Neurogene announces FDA clearance of IND for NGN-401 gene therapy for children with Rett syndrome; Rett syndrome is an X-linked, progressive, neurodevelopmental disorder that affects 1 in 10,000 live female births

AstraZeneca announces FDA decision to grant priority review for supplemental New Drug Application for Lynparza tablets in combination with abiraterone and prednisone or prednisolone; combination is a treatment for castration-resistant prostate cancer

FDA accepts Angion’s IND application for clinical development of biopharmaceutical ANG-3070 oral tyrosine kinase inhibitor to treat idiopathic pulmonary fibrosis; Angion to start enrollment in Phase 1B study, with 20 patients in crossover design trial

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count